Dilon Technologies

43 articles about Dilon Technologies

• Dilon Technologies Announces the Publication of Data Demonstrating Cost-Savings Results from the Use of MarginProbeTM Compared to a Full Cavity Shave (FCS) Approach

  9/22/2023

  Dilon Technologies Inc. announced today the publication of Cost Minimization in Breast Conserving Surgery: A Comparative Study of Radiofrequency Spectroscopy and Full Cavity Shave Margins for Patients Undergoing Breast Conserving Surgery, in the Journal of Cost Effectiveness and Resource Allocation.    

• SmartBreast™ Announces Molecular Breast Imaging Partnership with FITI

  2/9/2021

  After acquiring the Molecular Breast Imaging assets from GE Healthcare and Dilon Technologies, Inc., SmartBreast Corporation, a privately held company focused on breast cancer screening and diagnosis, announced that it has formed a partnership with FoxSemicon Integrated Technologies, Inc. to manufacture Molecular Breast Imaging systems.

• SmartBreast™ Acquires Molecular Breast Imaging Assets from Dilon Technologies®

  12/29/2020

  Smart Breast Corporation (SmartBreast™), a privately held company focused on breast cancer screening and detection, announced today that it has acquired certain Molecular Breast Imaging (MBI) assets from Dilon Technologies, Inc. (Dilon) for an undisclosed amount. The acquired MBI technology sees through dense breast tissue to fi

• Dilon Technologies® Inc. acquires the Dune Medical MarginProbe®

  4/2/2020

  Dilon Technologies® Inc., a world class global leader in breast cancer treatment and diagnosis and owner of the Navigator Gamma Probes has acquired substantially all the assets of Dune Medical, including Dune Medical's "MarginProbe".

• Dilon Technologies Announces the Launch of the New CoPilot VL+ Video Laryngoscope

  2/8/2018

  The new CoPilot VL+ boasts a larger, brighter, higher resolution display along with powerful LEDs to help the user obtain a better view of the airway.

• 

  Dilon Technologies Acquires the Copilot VL Video Laryngoscope

  12/29/2017

  The deal will expand Dilon's footprint into the anesthesia and airway space.

• Frost & Sullivan Acknowledges Dilon Technologies's Technical Capabilities, Commitment To Innovation, And Rise As A Technology Leader In Molecular Breast Imaging

  8/3/2016

• Dilon Technologies Introduces The New Purple Navigator 2.0 Gamma Probe System

  7/7/2016

• Dilon Technologies Release: Next Generation Breast Cancer Detection System, Molecular Breast Tomosynthesis, Presented At The 2016 Society Of Nuclear Medicine And Molecular Imaging Annual Meeting

  6/15/2016

• Dilon Technologies Receives CE Mark Approval For Its Navigator Gamma Probe System

  7/10/2014

• Dilon Technologies: Study Determines Breast-Specific Gamma Imaging Is More Effective Than Ultrasound in Patients With Complex Breast Tissue

  10/6/2010

• Dilon Technologies: First Lesion-Localization System for Molecular Breast Imaging Proves to Be Highly Effective for Gamma-Guided Biopsy: Results Presented Today at RSNA

  12/3/2009

• Dilon Technologies: Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI)

  11/19/2009

• Dilon Technologies: Breast Cancer Detection Goes Beyond Mammography to See What Matters New Technology

  10/13/2009

• Dilon Technologies Joins Forces With Philips Healthcare for Women's Health Solutions

  10/12/2009

• Dilon Technologies: Breast-Specific Gamma Imaging Proves Cost-Effective for Pre-Surgical Planning of Patients with Known Cancer Diagnosis

  10/9/2009

• Dilon Technologies Release: Breast-Specific Gamma Imaging (BSGI) Can Reduce the Number of Unnecessary Breast Biopsies When Compared to MRI

  3/18/2009

• Dilon Technologies's Breast-Specific Gamma Imaging (BSGI) Offers Greater Sensitivity Over Mammography, Ultrasound and MRI

  3/3/2009

• Dilon Technologies Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Breast Cancer in Newly Diagnosed Breast Cancer Patients

  2/27/2009

• Dilon Technologies Leads Molecular Breast Imaging Expansion; 35 Percent Increase in Sales

  2/10/2009